| 0 |
MULTIPLE EPIPHYSEAL DYSPLASIA |
3 |
0.1111 |
| 1 |
BLOOD BILIRUBIN UNCONJUGATED |
1 |
0.0714 |
| 2 |
BLOOD CANNABINOIDS INCREASED |
1 |
0.0417 |
| 3 |
DRUG METABOLISING ENZYME DECREASED |
1 |
0.0192 |
| 4 |
NATURAL KILLER CELL COUNT INCREASED |
1 |
0.0167 |
| 5 |
FAILED IN VITRO FERTILISATION |
1 |
0.0164 |
| 6 |
TOE WALKING |
1 |
0.0085 |
| 7 |
ELBOW DEFORMITY |
2 |
0.0058 |
| 8 |
IN VITRO FERTILISATION |
1 |
0.0055 |
| 9 |
HEPATOSPLENIC T-CELL LYMPHOMA |
2 |
0.0054 |
| 10 |
NEUROFIBROMATOSIS |
1 |
0.0048 |
| 11 |
VICTIM OF CHILD ABUSE |
1 |
0.0040 |
| 12 |
CSF PRESSURE INCREASED |
1 |
0.0038 |
| 13 |
BODY HEIGHT BELOW NORMAL |
2 |
0.0031 |
| 14 |
PANCREATIC ENLARGEMENT |
1 |
0.0027 |
| 15 |
GENE MUTATION IDENTIFICATION TEST POSITIVE |
1 |
0.0024 |
| 16 |
LOWER RESPIRATORY TRACT INFECTION VIRAL |
1 |
0.0020 |
| 17 |
LIPOHYPERTROPHY |
1 |
0.0016 |
| 18 |
IMPETIGO |
2 |
0.0013 |
| 19 |
LIMB ASYMMETRY |
1 |
0.0013 |
| 20 |
GENITAL INFECTION FUNGAL |
1 |
0.0012 |
| 21 |
ADRENOCORTICOTROPIC HORMONE DEFICIENCY |
1 |
0.0011 |
| 22 |
BINGE EATING |
1 |
0.0009 |
| 23 |
CHRONIC FATIGUE SYNDROME |
1 |
0.0007 |
| 24 |
GENITAL RASH |
1 |
0.0007 |
| 25 |
HYPOTHALAMO-PITUITARY DISORDER |
1 |
0.0007 |
| 26 |
PATHOLOGICAL GAMBLING |
1 |
0.0006 |
| 27 |
HYPERSEXUALITY |
1 |
0.0005 |
| 28 |
HYPERPHAGIA |
2 |
0.0005 |
| 29 |
LIPIDS INCREASED |
1 |
0.0005 |
| 30 |
FUNGAL SKIN INFECTION |
2 |
0.0005 |
| 31 |
COMPULSIVE SHOPPING |
1 |
0.0005 |
| 32 |
INSULIN RESISTANCE |
1 |
0.0005 |
| 33 |
TIC |
2 |
0.0004 |
| 34 |
CLONUS |
1 |
0.0004 |
| 35 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 36 |
GROWTH RETARDATION |
1 |
0.0003 |
| 37 |
HISTIOCYTOSIS HAEMATOPHAGIC |
1 |
0.0003 |
| 38 |
PRIAPISM |
1 |
0.0003 |
| 39 |
JAUNDICE CHOLESTATIC |
1 |
0.0003 |
| 40 |
PULMONARY FUNCTION TEST DECREASED |
1 |
0.0002 |
| 41 |
SYNOVIAL CYST |
1 |
0.0002 |
| 42 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 43 |
HYPOVOLAEMIC SHOCK |
1 |
0.0002 |
| 44 |
FOETAL DEATH |
1 |
0.0002 |
| 45 |
LEARNING DISABILITY |
1 |
0.0002 |
| 46 |
INTRACRANIAL PRESSURE INCREASED |
1 |
0.0002 |
| 47 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 48 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 49 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 50 |
OBSESSIVE-COMPULSIVE DISORDER |
1 |
0.0001 |
| 51 |
JOINT STIFFNESS |
3 |
0.0001 |
| 52 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 53 |
BONE DISORDER |
2 |
0.0001 |
| 54 |
NERVE COMPRESSION |
1 |
0.0001 |
| 55 |
ATELECTASIS |
1 |
0.0001 |
| 56 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 57 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 58 |
FOLLICULITIS |
1 |
0.0001 |
| 59 |
RETCHING |
2 |
0.0001 |
| 60 |
SKIN LACERATION |
1 |
0.0001 |
| 61 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 62 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 63 |
ACCIDENT |
1 |
0.0001 |
| 64 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 65 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 66 |
ABASIA |
2 |
0.0001 |
| 67 |
DRUG TOXICITY |
1 |
0.0001 |
| 68 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 69 |
INCORRECT DRUG ADMINISTRATION DURATION |
2 |
0.0001 |
| 70 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 71 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 72 |
PARALYSIS |
1 |
0.0001 |
| 73 |
HYPOKINESIA |
1 |
0.0001 |
| 74 |
GASTROENTERITIS |
1 |
0.0001 |
| 75 |
INJECTION SITE RASH |
2 |
0.0001 |
| 76 |
ANKLE FRACTURE |
1 |
0.0001 |
| 77 |
OBESITY |
1 |
0.0001 |
| 78 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 79 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 80 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 81 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 82 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 83 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 84 |
SKIN FISSURES |
1 |
0.0001 |
| 85 |
INTENTIONAL DRUG MISUSE |
1 |
0.0000 |
| 86 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 87 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 88 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 89 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 90 |
ORAL PAIN |
1 |
0.0000 |
| 91 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 92 |
LOCALISED INFECTION |
1 |
0.0000 |
| 93 |
RASH GENERALISED |
1 |
0.0000 |
| 94 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 95 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 96 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 97 |
NEEDLE ISSUE |
1 |
0.0000 |
| 98 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 99 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 100 |
EPILEPSY |
1 |
0.0000 |
| 101 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 102 |
MOOD SWINGS |
1 |
0.0000 |
| 103 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 104 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 105 |
CHOLELITHIASIS |
1 |
0.0000 |
| 106 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 107 |
CRYING |
1 |
0.0000 |
| 108 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 109 |
PANIC ATTACK |
1 |
0.0000 |
| 110 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 111 |
ARTHRITIS |
2 |
0.0000 |
| 112 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 113 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 114 |
DRUG ABUSE |
2 |
0.0000 |
| 115 |
HYPERHIDROSIS |
3 |
0.0000 |
| 116 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 117 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 118 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 119 |
HYPOKALAEMIA |
1 |
0.0000 |
| 120 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 121 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 122 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 123 |
FLUSHING |
2 |
0.0000 |
| 124 |
THERAPY CESSATION |
1 |
0.0000 |
| 125 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 126 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 127 |
NERVOUSNESS |
1 |
0.0000 |
| 128 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 129 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 130 |
OEDEMA |
1 |
0.0000 |
| 131 |
DEPENDENCE |
1 |
0.0000 |
| 132 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 133 |
WEIGHT INCREASED |
4 |
0.0000 |
| 134 |
HYPONATRAEMIA |
1 |
0.0000 |
| 135 |
CATARACT |
1 |
0.0000 |
| 136 |
IRRITABILITY |
1 |
0.0000 |
| 137 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 138 |
STOMATITIS |
1 |
0.0000 |
| 139 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 140 |
FEELING HOT |
1 |
0.0000 |
| 141 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 142 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 143 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 144 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 145 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 146 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 147 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 148 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 149 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 150 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 151 |
UNDERDOSE |
1 |
0.0000 |
| 152 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 153 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 154 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 155 |
URTICARIA |
2 |
0.0000 |
| 156 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 157 |
BALANCE DISORDER |
1 |
0.0000 |
| 158 |
COVID-19 |
2 |
0.0000 |
| 159 |
INSOMNIA |
3 |
0.0000 |
| 160 |
TACHYCARDIA |
1 |
0.0000 |
| 161 |
MUSCLE SPASMS |
2 |
0.0000 |
| 162 |
SWELLING |
1 |
0.0000 |
| 163 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 164 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 165 |
DYSPEPSIA |
1 |
0.0000 |
| 166 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 167 |
SINUSITIS |
1 |
0.0000 |
| 168 |
ERYTHEMA |
2 |
0.0000 |
| 169 |
ARTHRALGIA |
4 |
0.0000 |
| 170 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 171 |
INFLUENZA |
1 |
0.0000 |
| 172 |
ASTHMA |
1 |
0.0000 |
| 173 |
DEPRESSION |
2 |
0.0000 |
| 174 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 175 |
SEIZURE |
1 |
0.0000 |
| 176 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 177 |
CHILLS |
1 |
0.0000 |
| 178 |
FEELING ABNORMAL |
2 |
0.0000 |
| 179 |
JOINT SWELLING |
1 |
0.0000 |
| 180 |
PSORIASIS |
1 |
0.0000 |
| 181 |
VISION BLURRED |
1 |
0.0000 |
| 182 |
ANXIETY |
2 |
0.0000 |
| 183 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 184 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 185 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 186 |
NAUSEA |
5 |
0.0000 |
| 187 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 188 |
TREMOR |
1 |
0.0000 |
| 189 |
DIZZINESS |
3 |
0.0000 |
| 190 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 191 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 192 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 193 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 194 |
DYSPNOEA |
3 |
0.0000 |
| 195 |
PRURITUS |
2 |
0.0000 |
| 196 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 197 |
HYPERTENSION |
1 |
0.0000 |
| 198 |
BACK PAIN |
1 |
0.0000 |
| 199 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 200 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 201 |
DRUG INEFFECTIVE |
4 |
0.0000 |
| 202 |
ASTHENIA |
1 |
0.0000 |
| 203 |
FATIGUE |
2 |
0.0000 |
| 204 |
VOMITING |
1 |
0.0000 |
| 205 |
PAIN |
1 |
0.0000 |
| 206 |
HEADACHE |
1 |
0.0000 |
| 207 |
DIARRHOEA |
1 |
0.0000 |
| 208 |
OFF LABEL USE |
1 |
0.0000 |